Emergex Vaccines Holding Ltd: Emergex Strengthens Senior Management Team
Emergex Strengthens Senior Management Team
Appointments of Mr Robin Cohen as Business Development Director and Ms Susi Osborne as Manufacturing Director
Abingdon, Oxon, UK, 23 February 2021 - Emergex Vaccines Holding Limited ( Emergex , or the Company ), a company tackling major global infectious disease threats through the development of synthetic set point vaccines which prime the T-Cell immune response, today announces the appointment of Mr Robin Cohen, as Business Development Director. The Company is also pleased to announce the appointment of Ms Susi Osborne as Manufacturing Director, who joined Emergex in January this year.